Banco Comercial Portugues S/A (0NYY)
London Stock Exchange · UK · prices in GBP · close of 23 Oct 2026
Key indicators
| Last close | GBP 1.070 |
|---|---|
| 52-week range | 0.747 – 1.255 |
| Return, 1 month / 3 months | −9.0% / +1.8% |
| Return, 1 year / 3 years | +41.8% / +289.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 33 |
| Volatility (1 year) | 26.3% |
| Worst drawdown (1 year) | -17.2% |
| Average daily value traded | 7.22M GBP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Comercial Portugues is a Portuguese banking group that serves individuals, companies and institutional clients, mainly under the Millennium bcp brand. It offers current and savings accounts, mortgages, consumer and business lending, payment services, insurance and investment products through a branch network and digital channels. The group is based in Portugal and also operates in selected international markets, including Poland and parts of Africa, where it provides retail and commercial banking services to local customers.
The shares are listed on the London Stock Exchange in UK under the code 0NYY, and the price on this page is in pounds sterling (GBP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Comercial Portugues S/A (0NYY) trades on the London Stock Exchange in UK. It last closed at GBP 1.070 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 255 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 41.8% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.5% | ||
| From 52-week high | -13.1% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 21.6% | ||
| 12-month return, skipping the last month | 55.8% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.2% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 7.22M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.3% |
|---|---|
| 1 month | −9.0% |
| 3 months | +1.8% |
| 6 months | +21.6% |
| 1 year | +41.8% |
| 3 years | +289.1% |
| 5 years | +578.2% |
Signals
| 50-day / 200-day average | 1.144 / 0.986 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.028 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.